Muscle OxygenationNCT06906146
Capacitive Resistive Electric Transfer Therapy on Muscle Recovery
A study testing CRET therapy in people with Muscle Oxygenation and Lactate, run by Universitat Internacional de Catalunya.
Trial summary
This study aims to evaluate the effectiveness of Capacitive Resistive Electric Transfer (CRET) therapy combined with post-competition massage in the recovery and muscle function of professional athletes. It is designed as a randomized, double-blind, crossover clinical trial. Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Muscle Oxygenation, Lactate, Anaerobic Exercise
- What is being tested?
- CRET therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 10 Apr 2025to 10 Jun 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Athletes who practice a type of sport that requires the use of anaerobic muscle metabolism (cycling, athletics, triathlon, crossfit, spinning and duathlon)
- Athletes must be federated and train a minimum of 4 days/week
- Active participation in regional, national or international competitions.
Who cannot join
- Volunteers who have suffered a sports injury that makes it impossible for them to perform the test
- Having received the CRET therapy technique.
- Subjects who report allergies to the conductive cream.
- Subjects undergoing pharmacological medical treatment that may interfere with the measurements.
About this study
Official title: Effectivness of Capacitive Resistive Electric Transfer Therapy on Muscle Recovery in Athletes
This study aims to evaluate the effectiveness of Capacitive Resistive Electric Transfer (CRET) therapy combined with post-competition massage in the recovery and muscle function of professional athletes. It is designed as a randomized, double-blind, crossover clinical trial. The primary objective is to analyze the efficacy of this combined protocol in muscle recovery after performing the Wingate anaerobic power and capacity test. Secondary objectives include assessing changes in muscle fatigue, muscle function of the rectus femoris and vastus lateralis, physiological changes in blood lactate concentration and oxygen saturation, and intramuscular structural changes through ultrasound before and after the intervention.
The study will recruit professional athletes from disciplines that require anaerobic muscle metabolism, such as cycling, athletics, triathlon, CrossFit, and duathlon. Participants must be federated athletes who train at least four times per week and actively compete at regional, national, or international levels. Exclusion criteria include recent sports injuries preventing test performance, prior exposure to CRET therapy, allergies to conductive gel, language barriers, participation in other research studies, or ongoing pharmacological treatment that could interfere with measurements.
Read more
Participants will attend four study sessions, divided into two sets of two consecutive days. On the first day, they will perform the Wingate test followed by the assigned post-competition massage with either CRET therapy or a placebo intervention. On the second day, they will repeat the Wingate test. After a three-week washout period, participants will switch to the opposite group. The intervention group will receive a 60-minute CRET therapy session with both resistive and capacitive modes applied at different power intensities, combined with a standardized recovery massage. The placebo group will receive the same massage while undergoing a simulated CRET therapy, with the machine turned on but without power application to prevent participant awareness of the placebo condition.
The study will analyze various dependent variables, including Wingate test performance, blood lactate levels, subjective fatigue perception using the modified Borg scale, muscle stiffness and tone through myotonometry, muscle oxygen saturation via near-infrared spectroscopy (NIRS), cross-sectional muscle area and grayscale values from ultrasound imaging, body composition using a Tanita analyzer, maximum isometric quadriceps strength via handheld dynamometry, and muscle activity measured by surface electromyography (sEMG). Each of these variables will be assessed at specific time points before, during, and after the intervention.
The estimated sample size is approximately 50 subjects, with 25 participants per group, determined through a preliminary pilot study. Statistical analyses will be conducted using IBM SPSS Statistics 26.0. Descriptive statistics will be calculated for quantitative and qualitative variables. A linear mixed model will be applied to compare changes between and within groups over five measurement periods using a one-way mixed ANOVA. If the sphericity assumption is violated, the Greenhouse-Geisser correction will be applied. Statistically significant effects will undergo post-hoc analysis with Bonferroni correction for multiple comparisons. All originally enrolled participants will be included in the final analysis following an intention-to-treat approach, and effect sizes will be calculated using eta squared. The significance level will be set at p < 0.05.
- Conditions
- Muscle Oxygenation, Lactate, Anaerobic Exercise
- Being tested
- CRET therapy, Sham CRET Therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CRET therapyDevice
Capacitive Resistive Electric Transfer (CRET) therapy is a treatment modality that applies high-frequency electrical currents to stimulate tissue regeneration, enhance blood circulation, and reduce muscle pain. It operates through two modes: the capacitive mode, which targets superficial tissues such as skin and muscle, and the resistive mode, which penetrates deeper structures like tendons, ligaments, and joints. This technique is widely used in rehabilitation, sports physiotherapy, and pain management to accelerate muscle recovery and optimize neuromuscular function.
Sham CRET TherapyDevice
Same as CRET therapy but in a aham form.
| Study group | Role | What they receive |
|---|---|---|
| CRET therapy | Experimental | Not described Receives: Device: CRET therapy |
| Sham | Sham comparator | Not described Receives: Device: Sham CRET Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lactate
Capacitive resistive electrical transfer therapy (CRET) is a treatment modality that applies high-frequency electrical currents to stimulate tissue regeneration, improve blood circulation and reduce muscle pain. It works through two modes: the capacitive mode, which targets superficial tissues such as skin and muscle, and the resistive mode, which penetrates deeper structures such as tendons, ligaments and joints. This technique is widely used in rehabilitation, sports physiotherapy and pain management to accelerate muscle recovery and optimize neuromuscular function.
Measured: 1 hour after the test
Secondary outcomes (5)
Wingate Test
The Wingate test is used to determine power and anaerobic capacity (21). Each subject will perform the test: 30 seconds at maximum intensity interspersed with 1 minute of active recovery (pedaling 100 rpm), and this cycle will be repeated 3 times. The cycloergometer (Monark 818E, Vansbro, Sweden) will be used.
The test will be performed with a flywheel load resistance calculated based on 0.075 kg of the subject's current body weight. Heart rate during the test will be monitored with a heart rate monitor (Polar CS100 Cycling Heart Rate Monitor).
Measured: During the test
Muscle oxygen saturation percentage
Near infrared spectroscopy (NIRS) monitoring detects changes in tissue oxygenation in small blood vessels, capillaries and oxygen transport (e.g. myoglobin). This instrument determines the relationship between oxyhemoglobin concentration and total hemoglobin concentration in the muscle. The sensors will be attached to the vastus lateralis and rectus femoris muscles during the Wingate test.
Measured: During the test
Muscle thickness
Ultrasound (US) images were used (US Aloka Prosound C3 15.4) with a high-frequency linear transducer (USTTL01, 12 L5), measured by a researcher with more than 10 years of experience handling the instrument. Measurements were taken in the muscle belly of the vastus lateralis (i.e., in the same location as the NIRS measurements) and the rectus femoris, with the patient lying on the examination table, knees fully extended, and legs without rotation. Ultrasound imaging was always performed at the same point (marked with a dermographic pen), with the linear transducer placed at the same angle (perpendicular to the skin). The 90º angulation of the transducer was verified before each measurement using a goniometer. The transducer was positioned without applying force to the skin, merely making contact with the ultrasound gel. Ultrasound device settings were adjusted for each patient to optimize the visualization of the target tissue, and the same settings were maintained for all measurements
Measured: 1 hour after the test
Maximal voluntary knee extension force
before (at rest) and the day after (24h after the end of the Wingate test and recovery intervention), subject performed a 5s isometric maximal voluntary contraction to measure the maximal voluntary force of the knee extensor muscles. The force was registered in the dominant lower limb and the unit of measure was Newtons. A traction dynamometer (PCE Ibérica S.L., Albacete, Spain) was used. During the assessment, participants were seated with their hips and knees flexed at a 90o angle, and a strap was secured on the distal and anterior part of the dominant leg. The test was repeated three times, and the mean value was used for the analysis. Verbal encouragements were given throughout the contraction time.
Measured: Before the test
muscle activity
muscle activity was recorded using surface electromyography from vastus lateralis and rectus femoris. The data was obtained by consists of three parts: (a) a Shimmer3 sEMG unit (Realtime Technologies Ltd., Dublin, Ireland). The signal was smoothed using a window size of 0.025s root mean square (RMS) and an overlapping of 0.0125s between windows. The Maximal Voluntary Isometric Contraction (MVIC) was calculated using the peak of the RMS signal during the extension knee isometric test. The RMS was the principal variable recorded for muscle activity. The participants' skin was cleaned with alcohol and dried before the electrodes were placed. If hair impeded the correct adhesion of the electrodes to the skin, the particular site was shaved. Self-adhesive 5×5 cm Valutrode® surface electrodes were placed on the muscle bellies according to the SENIAM project recommendations and with an interelectrode distance of 20 mm. Vastus lateralis electrodes were placed between the line from
Measured: Before the test
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Apr 2025
- Study start10 Apr 2025 (estimated)
- Primary completion10 May 2025 (estimated)
- Study completion10 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Muscle OxygenationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Universitat Internacional de Catalunya
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06906146
- Sponsor's protocol ID
- CBAS-2023-03
- Status last verified
- Mar 2025
- First submitted
- 6 Mar 2025
- Last updated
- 2 Apr 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Canet-Vintro M, Oviedo GR, Lopez-de-Celis C, Beltrame T, Muniz-Pardos B, Mengual I, Rodriguez-Sanz J. Muscle Massage Adding Capacitive Resistive Electric Transfer Therapy in Active or Sham Condition for Post-Exercise Recovery in Athletes: A Crossover Clinical Trial. Eur J Sport Sci. 2026 Oct;26(10):e70246. doi: 10.1002/ejsc.70246.
PubMed 42733310
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectivness of Capacitive Resistive Electric Transfer Therapy on Muscle Recovery in Athletes
- ClinicalTrials.gov ID
- NCT06906146
- Acronym / sponsor ID
- CBAS-2023-03
- Conditions
- Muscle Oxygenation, Lactate, Anaerobic Exercise
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Universitat Internacional de CatalunyaUniversity, hospital or other
- Study start
- 10 Apr 2025 (estimated)
- Primary completion
- 10 May 2025 (estimated)
- Study completion
- 10 Jun 2025 (estimated)
- First posted
- 2 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effectiveness of Capacitive Resistive Electric Transfer (CRET) therapy combined with post-competition massage in the recovery and muscle function of professional athletes. It is designed as a randomized, double-blind, crossover clinical trial. The primary objective is to analyze the efficacy of this combined protocol in muscle recovery after performing the Wingate anaerobic power and capacity test. Secondary objectives include assessing changes in muscle fatigue, muscle function of the rectus femoris and vastus lateralis, physiological changes in blood lactate concentration and oxygen saturation, and intramuscular structural changes through ultrasound before and after the intervention.
The study will recruit professional athletes from disciplines that require anaerobic muscle metabolism, such as cycling, athletics, triathlon, CrossFit, and duathlon. Participants must be federated athletes who train at least four times per week and actively compete at regional, national, or international levels. Exclusion criteria include recent sports injuries preventing test performance, prior exposure to CRET therapy, allergies to conductive gel, language barriers, participation in other research studies, or ongoing pharmacological treatment that could interfere with measurements.
Participants will attend four study sessions, divided into two sets of two consecutive days. On the first day, they will perform the Wingate test followed by the assigned post-competition massage with either CRET therapy or a placebo intervention. On the second day, they will repeat the Wingate test. After a three-week washout period, participants will switch to the opposite group. The intervention group will receive a 60-minute CRET therapy session with both resistive and capacitive modes applied at different power intensities, combined with a standardized recovery massage. The placebo group will receive the same massage while undergoing a simulated CRET therapy, with the machine turned on but without power application to prevent participant awareness of the placebo condition.
The study will analyze various dependent variables, including Wingate test performance, blood lactate levels, subjective fatigue perception using the modified Borg scale, muscle stiffness and tone through myotonometry, muscle oxygen saturation via near-infrared spectroscopy (NIRS), cross-sectional muscle area and grayscale values from ultrasound imaging, body composition using a Tanita analyzer, maximum isometric quadriceps strength via handheld dynamometry, and muscle activity measured by surface electromyography (sEMG). Each of these variables will be assessed at specific time points before, during, and after the intervention.
The estimated sample size is approximately 50 subjects, with 25 participants per group, determined through a preliminary pilot study. Statistical analyses will be conducted using IBM SPSS Statistics 26.0. Descriptive statistics will be calculated for quantitative and qualitative variables. A linear mixed model will be applied to compare changes between and within groups over five measurement periods using a one-way mixed ANOVA. If the sphericity assumption is violated, the Greenhouse-Geisser correction will be applied. Statistically significant effects will undergo post-hoc analysis with Bonferroni correction for multiple comparisons. All originally enrolled participants will be included in the final analysis following an intention-to-treat approach, and effect sizes will be calculated using eta squared. The significance level will be set at p < 0.05.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| CRET therapy | Experimental | Device: CRET therapy |
| Sham | Sham comparator | Device: Sham CRET Therapy |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Athletes who practice a type of sport that requires the use of anaerobic muscle metabolism (cycling, athletics, triathlon, crossfit, spinning and duathlon)
- Athletes must be federated and train a minimum of 4 days/week
- Active participation in regional, national or international competitions.
Key exclusion criteria (4 listed)
- Volunteers who have suffered a sports injury that makes it impossible for them to perform the test
- Having received the CRET therapy technique.
- Subjects who report allergies to the conductive cream.
- Subjects undergoing pharmacological medical treatment that may interfere with the measurements.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CRET therapyCapacitive Resistive Electric Transfer (CRET) therapy is a treatment modality that applies high-frequency electrical currents to stimulate tissue regeneration, enhance blood circulation, and reduce muscle pain. It operates through two modes: the capacitive mode, which targets superficial tissues such as skin and muscle, and the resistive mode, which penetrates deeper structures like tendons, ligaments, and joints. This technique is widely used in rehabilitation, sports physiotherapy, and pain management to accelerate muscle recovery and optimize neuromuscular function. | Device | CRET therapy |
| Sham CRET TherapySame as CRET therapy but in a aham form. | Device | Sham |
Primary outcome
Lactate
Time frame: 1 hour after the test
Capacitive resistive electrical transfer therapy (CRET) is a treatment modality that applies high-frequency electrical currents to stimulate tissue regeneration, improve blood circulation and reduce muscle pain. It works through two modes: the capacitive mode, which targets superficial tissues such as skin and muscle, and the resistive mode, which penetrates deeper structures such as tendons, ligaments and joints. This technique is widely used in rehabilitation, sports physiotherapy and pain management to accelerate muscle recovery and optimize neuromuscular function.
5 secondary outcomes
Wingate Test
Time frame: During the test
Muscle oxygen saturation percentage
Time frame: During the test
Muscle thickness
Time frame: 1 hour after the test
Maximal voluntary knee extension force
Time frame: Before the test
muscle activity
Time frame: Before the test
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2025.
- Derived from this study: PubMed 42733310Canet-Vintro M, Oviedo GR, Lopez-de-Celis C, Beltrame T, Muniz-Pardos B, Mengual I, Rodriguez-Sanz J. Muscle Massage Adding Capacitive Resistive Electric Transfer Therapy in Active or Sham Condition for Post-Exercise Recovery in Athletes: A Crossover Clinical Trial. Eur J Sport Sci. 2026 Oct;26(10):e70246. doi: 10.1002/ejsc.70246.
- Individual participant dataSharing planned: No
Related trials for Muscle Oxygenation
Recruiting
Acute Effects of Post-Exercise Hyperoxia on Recovery in Cycling
Athletic Performance, Hyperbaric Oxygenation
Recruiting
The Effect of Different Exercise Training Programs on Muscle Oxygenation in Individuals With Knee Osteoarthritis
Osteoarthritis of Knee
Not yet recruiting
Quadriceps Muscle Activation and Oxygenation Responses During Usual Care Compared to Individualized Interval and Constant Work Rate Bed-cycling. An Experimental Study.
Critical Illness
Not yet recruitingObservational study
Trapezius Oxygenation and Cervical Function in Chronic Neck Pain
Chronic Neck Pain
RecruitingObservational study
The Forgotten Role of Back Muscle Characteristics to Tailor Exercise Therapy for Recurrent Non-specific Low Back Pain
Low Back Pain, Back Pain Lower Back Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing CRET therapy in people with Muscle Oxygenation and Lactate, run by Universitat Internacional de Catalunya.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lactate (time frame: 1 hour after the test). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06906146, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.